BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28831010)

  • 1. Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis.
    Ke L; Zhou H; Wang C; Xiong G; Xiang Y; Ling Y; Khabir A; Tsao GS; Zeng Y; Zeng M; Busson P; Kieff E; Guo X; Zhao B
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9683-9688. PubMed ID: 28831010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancer infestation drives tumorigenic activation of inactive B compartment in Epstein-Barr virus-positive nasopharyngeal carcinoma.
    Mizokami H; Okabe A; Choudhary R; Mima M; Saeda K; Fukuyo M; Rahmutulla B; Seki M; Goh BC; Kondo S; Dochi H; Moriyama-Kita M; Misawa K; Hanazawa T; Tan P; Yoshizaki T; Fullwood MJ; Kaneda A
    EBioMedicine; 2024 Apr; 102():105057. PubMed ID: 38490101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ΔNp63α is a super enhancer-enriched master factor controlling the basal-to-luminal differentiation transcriptional program and gene regulatory networks in nasopharyngeal carcinoma.
    Cai J; Chen S; Yi M; Tan Y; Peng Q; Ban Y; Yang J; Li X; Zeng Z; Xiong W; McCarthy JB; Li G; Li X; Xiang B
    Carcinogenesis; 2020 Sep; 41(9):1282-1293. PubMed ID: 31826234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of DNA methylation in Epstein-Barr virus-associated nasopharyngeal carcinoma by bisulfite amplicon sequencing.
    Zhao W; Mo Y; Wang S; Midorikawa K; Ma N; Hiraku Y; Oikawa S; Huang G; Zhang Z; Murata M; Takeuchi K
    BMC Cancer; 2017 Jul; 17(1):489. PubMed ID: 28716111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Super-enhancer driven SOX2 promotes tumor formation by chromatin re-organization in nasopharyngeal carcinoma.
    Liu SX; Wang C; Lin RB; Ding WY; Roy G; Wang HB; Yang T; Liu Q; Luo YL; Jin SL; Zeng MS; Zhao B; Zhong Q
    EBioMedicine; 2023 Dec; 98():104870. PubMed ID: 37967508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant SATB1 expression is associated with Epstein-Barr virus infection, metastasis and survival in human nasopharyngeal cells and endemic nasopharyngeal carcinoma.
    Deng YF; Zhou DN; Pan ZY; Yin P
    Int J Clin Exp Pathol; 2014; 7(5):2454-61. PubMed ID: 24966956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
    Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
    J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BET bromodomain inhibitor JQ1 preferentially suppresses EBV-positive nasopharyngeal carcinoma cells partially through repressing c-Myc.
    Li N; Yang L; Qi XK; Lin YX; Xie X; He GP; Feng QS; Liu LR; Xie X; Zeng YX; Feng L
    Cell Death Dis; 2018 Jul; 9(7):761. PubMed ID: 29988031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-κB axis during nasopharyngeal carcinoma development.
    Liu Y; Gong P; Zhou N; Zhang J; He C; Wang S; Peng H
    Biochem Biophys Res Commun; 2019 Jun; 514(1):127-133. PubMed ID: 31027734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr Virus-Induced VEGF and GM-CSF Drive Nasopharyngeal Carcinoma Metastasis via Recruitment and Activation of Macrophages.
    Huang D; Song SJ; Wu ZZ; Wu W; Cui XY; Chen JN; Zeng MS; Su SC
    Cancer Res; 2017 Jul; 77(13):3591-3604. PubMed ID: 28484077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of ATOH8 induced by EBV-encoded LMP1 contributes to the malignant phenotype of nasopharyngeal carcinoma.
    Wang Z; Xie J; Yan M; Wang J; Wang X; Zhang J; Zhang Y; Li P; Lei X; Huang Q; Lin S; Guo X; Liu Q
    Oncotarget; 2016 May; 7(18):26765-79. PubMed ID: 27049918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational genomics of nasopharyngeal cancer.
    Tsang CM; Lui VWY; Bruce JP; Pugh TJ; Lo KW
    Semin Cancer Biol; 2020 Apr; 61():84-100. PubMed ID: 31521748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic S1P signalling in EBV-associated nasopharyngeal carcinoma activates AKT and promotes cell migration through S1P receptor 3.
    Lee HM; Lo KW; Wei W; Tsao SW; Chung GTY; Ibrahim MH; Dawson CW; Murray PG; Paterson IC; Yap LF
    J Pathol; 2017 May; 242(1):62-72. PubMed ID: 28240350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma.
    Shu XS; Li L; Ji M; Cheng Y; Ying J; Fan Y; Zhong L; Liu X; Tsao SW; Chan AT; Tao Q
    Carcinogenesis; 2013 Sep; 34(9):1984-93. PubMed ID: 23677067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TEL2 suppresses metastasis by down-regulating SERPINE1 in nasopharyngeal carcinoma.
    Sang Y; Chen MY; Luo D; Zhang RH; Wang L; Li M; Luo R; Qian CN; Shao JY; Zeng YX; Kang T
    Oncotarget; 2015 Oct; 6(30):29240-53. PubMed ID: 26335051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
    Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and Characterization of an Epstein-Barr Virus-positive Cell Line from a Non-keratinizing Differentiated Primary Nasopharyngeal Carcinoma.
    Chai AWY; Yee SM; Lee HM; Abdul Aziz N; Yee PS; Marzuki M; Wong KW; Chiang AKS; Chow LK; Dai W; Liu TF; Tan LP; Khoo ASB; Lo KW; Lim PVH; Rajadurai P; Lightfoot H; Barthorpe S; Garnett MJ; Cheong SC
    Cancer Res Commun; 2024 Mar; 4(3):645-659. PubMed ID: 38358347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein-Barr virus by whole-genome sequencing.
    Tu C; Zeng Z; Qi P; Li X; Guo C; Xiong F; Xiang B; Zhou M; Liao Q; Yu J; Li Y; Li X; Li G; Xiong W
    Carcinogenesis; 2018 Dec; 39(12):1517-1528. PubMed ID: 30102338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.